-
The ISSCR Announces New Global Advisory Council Chairpersons
Dr. Susan Lim and Mr. Deepak Sharma are appointed chairpersons of the ISSCR Global Advisory Council, which brings together academic, business, corporate, civic and philanthropic leaders interested in supporting the society in its mission to transform human health worldwide.Full story -
Rudolf Jaenisch Assumes Leadership of the International Society for Stem Cell Research
The International Society for Stem Cell Research (ISSCR) is pleased to announce Rudolf Jaenisch, Whitehead Institute for Biomedical Research and Massachusetts Institute of Technology (MIT), as incoming president of the ISSCR board of directors, immediately following the ISSCR’s 12th Annual Meeting, June 18-21, 2014. Jaenisch will serve as president for one year and succeeds Janet Rossant. The role of vice president will be filled by Sally Temple, Neural Stem Cell Institute.Full story -
Stem Cells May be Key to Curing Retinal Disease
Robin Ali, Ph.D., UCL Institute of Ophthalmology in London, has developed a strategy for repairing the retina by transplanting photoreceptor cells generated in the laboratory from embryonic stem cells.Full story -
Organoids Offer Stem Cell Experts a Window into Kidney Disease
Stem cell researchers are now using organoids, lab-grown models of human organs, to better understand kidney disease. In the future, organoids may also provide an important test model for experimental drugs.Full story -
Details of ISSCR 12th Annual Meeting
The ISSCR 12th Annual Meeting will take place June 18-21, 2014 at the Vancouver Convention Centre in Vancouver, British Columbia, Canada. The meeting will bring together approximately 4,000 stem cell scientists, bioethicists, clinicians and industry professionals from over 50 countries to present and discuss the latest research and technologies within the field.Full story -
Human Disease Modeling Under the Microscope
Induced pluripotent stem cells (iPS cells) have been hailed as a future cell therapy, but they are playing an equally important role in research, revolutionizing the way scientists study human disease. By cultivating human stem cell lines in a dish, scientists are better able to understand diseases, including those with unique genetic markers.Full story -
Two Papers Open a New Window into Pluripotency
The ISSCR is pleased to help spread the news about two papers published online today in Nature that describe the induction of pluripotency in cells from a newborn mouse without the use of extrinsic transcription factors, chemical manipulation or nuclear transfer.Full story -
The ISSCR Announces 2014 Awards Recipients
The ISSCR announces recipients of its 2014 awards, which will be presented at the 12th Annual Meeting in Vancouver, taking place June 18-21, 2014.Full story -
Workshop, "Stem Cell Therapies: Opportunities for Assuring the Quality and Safety of Unregulated Clinical Offerings"
The ISSCR, the Institute of Medicine and the National Academy of Sciences, is hosting a Washington, DC-based workshop and live webcast examining the practice and consequences of unproven stem cell treatments on November 18, 2013 from 8:30 a.m.-5:30 p.m. EDTFull story -
ISSCR Statement of Delivery of Unproven Autologous Cell-based Interventions to Patients
The International Society for Stem Cell Research (ISSCR) urges medical licensing bodies, legal authorities, patient advocacy organizations, physicians, and others to exercise their influence to discourage commercial provision of unproven autologous cell-based interventions outside of clinical trials.Full story -
ISSCR Celebrates Inaugural Issue of its Open Access Journal, Stem Cell Reports
The International Society for Stem Cell Research (ISSCR) is excited to announce the inaugural issue of Stem Cell Reports, the society’s new open-access journal, published today. Stem Cell Reports, published for the ISSCR by Cell Press, presents high-quality, peer-reviewed research presenting conceptual or practical advances across the breadth of stem cell research and its applications to medicine, with a focus on shorter, single-point articles.Full story -
ISSCR Emphasizes Importance of Regulatory Oversight for Stem Cell Products for Clinical Use
The ISSCR urges Italian lawmakers to heed concerns of scientists around the world about the premature practice of unproven stem cell treatments and to recognize the importance of regulatory oversight and patient protection when developing new stem cell medicines.Full story -
ISSCR Voices Concern as Italian Government Authorizes Unproven Stem Cell Therapy
The International Society for Stem Cell Research (ISSCR) voices concern as the Italian government authorizes an unproven stem cell therapy for use in patients.Full story -
ISSCR President, Board Member, and 11th Annual Meeting Keynote Speaker Among Winners of Breakthrough Prize
ISSCR President, Shinya Yamanaka, Board of Directors member Hans Clevers and the ISSCR 2013 Annual Meeting Keynote Speaker Eric Lander, were three of 11 distinguished recipients of the inaugural Breakthrough Prize in Life Sciences, announced todayFull story -
ISSCR Statement on U.S. Supreme Court decision to deny certiorari in case of Sherley v. Sebelius
The International Society for Stem Cell Research (ISSCR) welcomes the decision of the US Supreme Court to deny certiorari in the case of Sherley v Sebelius, which had challenged federal funding of human embryonic stem cell research.Full story